Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation

Genes and Development

Volumn 10, Issue 20, 1996, Pages 2577-2587

  Mishina, Yuji ^a   Rey, Rodolfo ^b   Finegold, Milton J ^c   Matzuk, Martin M ^c   Josso, Nathalie ^b   Cate, Richard L ^d   Behringer, Richard R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d BIOGEN   (United States)

Author keywords

anti Mullerian hormone; testis; TGF gene family; tumorigenesis

Indexed keywords

MUELLERIAN INHIBITING FACTOR; TRANSFORMING GROWTH FACTOR BETA; INHIBIN; LIGAND; MULLERIAN INHIBITING SUBSTANCE RECEPTOR; MULLERIAN-INHIBITING SUBSTANCE RECEPTOR; RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC ANALYSIS; GRANULOSA CELL; LEYDIG CELL; MESENCHYME CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOHERMAPHRODITISM; SEMINIFEROUS TUBULE; SERTOLI CELL; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; SPERMATOZOON MIGRATION; TESTIS; ALLELE; ANIMAL; C57BL MOUSE; CARCINOGEN TESTING; FEMALE; FERTILITY; GENETICS; GERM CELL; HYPERPLASIA; MALE; METABOLISM; PATHOPHYSIOLOGY; RABBIT; TESTIS TUMOR;

ANIMALIA; MAMMALIA;

ALLELES; ANIMALS; CARCINOGENICITY TESTS; FEMALE; FERTILITY; GERM CELLS; HYPERPLASIA; INHIBINS; LEYDIG CELLS; LIGANDS; MALE; MICE; MICE, INBRED C57BL; PSEUDOHERMAPHRODITISM; RABBITS; RECEPTORS, PEPTIDE; SEMINIFEROUS TUBULES; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS;

EID: 0029658831     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.20.2577     Document Type: Article

References (55)

1. Attisano, L., J.L. Wrana, S. Cheifetz, and J. Massagué. 1992. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68: 97-108.
2. Attisano, L., J. Cárcamo, F. Ventura, F.M.B. Weis, J. Massagué, and J.L. Wrana. 1993. Identification of human activin and TGFβ type I receptors that form heterodimeric kinase complexes with type II receptors. Cell 75: 671-680.
3. Baarends, W.M., M.J.L. van Helmond, M. Post, J.C.M. van der Schoot, J.W. Hoogerbrugghe, J.P. de Winter, J.T.J. Uilenbroek, B. Karels, L.G. Wilming, J.H.C. Meijers, A.P.N. Themmen, and J.A. Grootegoed. 1994. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 120: 189-197.
4. Baarends, W.M., J.W. Hoogerbrugghe, M. Post, J.A. Visser, D.G. de Rooij, M. Parvinen, A.P.N. Themmen, and J.A. Grootegoed. 1995a. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Endocrinology 136: 5614-5622.
5. Baarends, W.M., J.T.J. Uilenbroek, P. Kramer, J.W. Hoogerbrugghe, J.P. de Winter, B. Karels, L.G. Wilming, E.C.M. van Leeuwen, A.P.N. Themmen, and J.A. Grootegoed. 1995b. Anti-Mülerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136: 4951-4962.
6. Behringer, R.R., R.L. Cate, G.J. Froelick, R.D. Palmiter, and R.L. Brinster. 1990. Abnormal sexual development in transgenic mice chronically expressing Müllerian inhibiting substance. Nature 345: 167-170.
7. Behringer, R.R., M.J. Finegold, and R.L. Cate. 1994. Müllerian- inhibiting substance function during mammalian sexual development. Cell 79: 415-425.
8. Bradley, A. 1987. Production and analysis of chimeric mice. In Teratocarcinomas and embryonic stem cells: A practical approach (ed. E.J. Robertson), pp. 113-151. IRL Press, Oxford, UK.
9. Carré-Eusèbe, D., S. Imbeaud, M. Harbison, M.I. New, N. Josso, and J.-Y. Picard. 1992. Variants of the anti-Müllerian hormone gene in a compound heterozygotes with the persistent Müllerian duct syndrome and his family. Hum. Genet. 90: 389-394.
10. Chomczynski, P. and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal. Biochem. 162: 156-159.
11. Cohen-Haguenauer, O., J.-Y. Picard, M.G. Mattei, S. Serero, V.C. Nguyen, M.F. de Tand, D. Guerrier, M.C. Hors-Cayla, N. Josso, and J. Frézal. 1987. Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenet. Cell. Genet. 44: 2-4.
12. di Clemente, N., C. Wilson, E. Faure, L. Boussin, P. Carmillo, R. Tizard, J.-Y. Picard, B. Vigier, N. Josso, and R. Cate. 1994. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol. Endocrinol. 8: 1006-1020.
13. Ebner, R., R.-H. Chen, L. Shum, S. Lawler, T.F. Zioncheck, A. Lee, A.R. Lopez, and R. Derynck. 1993. Cloning of a type I TGFβ receptor and its effect on TGFβ binding to the type II receptor. Science 260: 1344-1348.
14. Franzén, P. P. ten Dijke, H. Ichijo, H. Yamshita, P. Schul, C.-H. Heldin, and K. Miyazono. 1993. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75: 681-692.
15. Franzén, P., C.-H. Heldin, and K. Miyazono. 1995. The GS domain of the transforming growth factor-beta type 1 receptor is important in signal transduction. Biochem. Biophys. Res. Comm. 207: 682-689.
16. Guerrier, D., D. Tran, J.M. Vanderwinden, S. Hideux, L. Van Outryve, L. Legeai, M. Bouchard, V.G. Van, J.-Y. Picard, A. Kahn, and N. Josso. 1989. The persistent Müllerian duct syndrome: A molecular approach. J. Clin. Endocrinol. Metab. 68: 46-52.
17. Hacker, A., B. Capel, P. Goodfellow, and R. Lovell-Badge. 1995. Expression of Sry, the mouse sex determining gene. Development 121: 1603-1614.
18. He, W.W., M.L. Gustafson, S. Hirobe, and P.K. Donahoe. 1993. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev. Dyn. 196: 133-142.
19. Imbeaud, S., D. Carreàbe, R. Rey, C. Belville, N. Josso, and J.-Y. Picard. 1994. Molecular genetics of the persistent Müllerian duct syndrome: A study of 19 families. Hum. Mol. Genet. 3: 125-131.
20. Imbeaud, S., E. Faure, I. Lamarre, M.-G. Mattéi, N. di Clemente, R. Tizzard, D. Carré-Eusèbe, C. Belville, L. Tragethon, C. Tonkin, J. Nelson, M. McAuliffe, J.-M. Bidat, A. Lababidi, N. Josso, R.L. Cate, and J.-Y. Picard. 1995. Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor. Nature Genet. 11: 382-388.
21. Imbeaud, S., C. Belville, L. Messika-Zeitoin, R. Rey, N. di Clemente, N. Josso, and J.-Y. Picard. 1996. A 27 base-pair deletion of the anti-Müllerian type II receptor gene is the most common cause of the persistent Müllerian duct syndrome. Hum. Mol. Genet. (in press).
22. Josso, N., R.L. Cate, J.-Y. Picard, B. Vigier, N. di Clemente, C. Wilson, S. Imbeaud, R.B. Pepinsky, D. Guerrier, L. Boussin, L. Legeai, and D. Carré-Eusèbe. 1993. Anti-Müllerian hormone the Jost factor. Recent Prog. Horm. Res. 48: 1-59.
23. Jost, A. 1953. Problems of fetal endocrinology: The gonadal and hypophyseal hormones. Recent Prog. Horm. Res. 8: 379-418.
24. Kaufman, M.H. 1990. In Postimplantation mammalian embryos, a practical approach (ed. A.J. Copp and D.L. Cockroft), pp. 81-91. IRL Press, Oxford, UK.
25. Kingsley, D.M. 1994. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes & Dev. 8: 133-146.
26. Knebelmann, B., L. Boussin, D. Guerrier, L. Legeai, A. Kahn, N. Josso, and J.-Y. Picard. 1991. Anti-Müllerian hormone Bruxelles: A non-sense mutation in the last exon of the anti Müllerian hormone gene associated with the persistent Müllerian duct syndrome in three brothers. Proc. Natl. Acad. Sci. 88: 3767-3771.
27. Koenig B.B., J.S. Cook, D.H. Wolsing, J. Ting, J.P. Tiesman, P.E. Correa, C.A. Olson, A.L. Pecquet, F. Ventura, R.A. Grant, G.-X. Chen, J.L. Wrana, J. Massagué, and J.S. Rosenbaum. 1994. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol. 14: 5961-5974.
28. Lyet, L., F. Louis, M.G. Forest, N. Josso, R.R. Behringer, and B. Vigier. 1995. Ontogeny of reproductive abnormalities induced by deregulation of anti-Müllerian hormone expression in transgenic mice. Biol. Reprod. 52: 444-454.
29. McMahon, A.P. and A. Bradley. 1990. The Wnt-1 (int-1) protooncogene is required for development of a large region of the mouse brain. Cell 62: 1073-1085.
30. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to nonselectable genes. Nature 336: 348-352.
31. Massagué, J., L. Attisano, and J.L. Wrana. 1994. The TGF-β family and its composite receptors. Trends Cell Biol. 4: 172-178.
32. Matsuzaki, K., J. Xu, F. Wang, W.L. McKeehan, L. Krummen, and M. Kan. 1993. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenetic factor. J. Biol. Chem. 268: 12718-12723.
33. Matzuk, M.M., M.J. Finegold, J.-G.J. Su, A.J.W. Hsueh, and A. Bradley. 1992. α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-319.
34. Matzuk, M.M., M.J. Finegold, Y. Mishina, A. Bradley, and R.R. Behringer. 1995a. Synergistic effects of inhibins and Müllerian-inhibiting substance on testicular tumorigenesis. Mol. Endocrin. 9: 1337-1345.
35. Matzuk, M.M., T.R. Kumar, and A. Bradley. 1995b. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374: 356-360.
36. Matzuk, M.M., T.R. Kumar, A. Vassalli, J.R. Bickenbach, D.R. Roop, R. Jaenisch, and A. Bradley. 1995c. Functional analysis of activins during development. Nature 374: 354-356.
37. Meyers-Wallen, V.N., P.K. Donahoe, S. Ueno, T.F. Manganaro, and D.F. Patterson. 1989. Müllerian inhibiting substance is present in testes of dogs with persistent Müllerian duct syndrome. Biol. Reprod. 41: 881-888.
38. Mishina, Y., A. Suzuki, N. Ueno, and R.R. Behringer. 1995. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes & Dev. 206: 310-317.
39. Münsterberg, A., and R. Lovell-Badge. 1991 Expression of the mouse anti-Müllerian hormone gene suggests a role in both male and female sexual differentiation. Development 113: 613-624.
40. Naguib, K.K., A.S. Teebi, S.A. Al-Awadi, M.Y. El-Khalifa, and E.S. Mahfouz. 1989. Familial uterine hernia syndrome: Report of an Arab family with four affected males. Am. J. Hum. Genet. 33: 180-181.
41. Sloan, W.R. and P.C. Walsh. 1976. Familial persistent Müllerian duct syndrome. J. Urol. 115: 459-461.
42. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
43. Suzuki, A., N. Shioda, T. Maeda, M. Tada, and N. Ueno. 1994. A mouse TGF-β type I receptor that requires type II receptor for ligand binding. Biochem. Biophys. Res. Comm. 298: 1063-1069.
44. Teixeira, J., W.W. He, P.C. Shah, N. Morikawa, M.M. Lee, E.A. Catlin, P.L. Hudson, J. Wing, D.T. Maclaughlin, and P.K. Donahoe. 1996. Developmental expression of a candidate Müllerian inhibiting substance type II receptor. Endocrinology 137: 160-165.
45. ten Dijke, P., H. Ichijo, P. Franzén, P. Schulz, J. Saras, H. Toyoshima, C.-H. Heldin, and K. Miyazono. 1993. Activin receptor-like kinases: A novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879-2887.
46. ten Dijke, P., H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevez, D.L. Riddle, H. Ichijo, C.-H. Heldin, and K. Miyazono. 1994. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985-16988.
47. Vale, W., A. Hsueh, C. Rivier, and J. Yu. 1990. The inhibin/activin family of hormones and growth factors. In Peptide growth factors and their receptors II (ed. M.B. Sporn and A.B. Roberts), pp. 211-248. Springer-Verlag, Germany.
48. Vassalli, A., M.M. Matzuk, H.A.R. Gardner, K.-F. Lee, and R. Jaenisch. 1994. Activin/inhibin βB subunit gene disruption leads to defects in eyelid development and female reproduction. Genes & Dev. 8: 414-427.
49. Vigier, B., J.-Y. Picard, D. Tran, L. Legai, and N. Josso. 1984. Production of anti-Müllerian hormone: Another homology between Sertoli and granulosa cells. Endocrinology 114: 1315-1320.
50. Vigier, B., F. Watrin, S. Magre, D. Tran, and N. Josso. 1987. Purified bovine AMH induces a characteristic freemartin effect in fetal rat prospective ovaries exposed to it in vitro. Development 100: 43-55.
51. Visser, J.A., A. McLuskey, T. van Beers, D.O. Weghuis, A.G. van Kessel, J.A. Grootegoed, and A.P. Themmen. 1995. Structure and chromosomal localization of the human anti-Müllerian hormone type II receptor gene. Biochem. Biophys. Res. Commun. 215: 1029-1036.
52. Winnier, G., M. Blessing, P.A. Labosky, and B.L.M. Hogan. 1995. Bone morphogenetic protein-4 (BMP-4) is required for mesoderm formation and patterning in the mouse. Genes & Dev. 9: 2105-2116.
53. Wrana, J.L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-β receptor. Nature 370: 341-347.
54. Yamaji, N., A.J. Celeste, R.S. Thies, J.J. Song, S.M. Bernier, D. Goltzman, K.M. Lyons, J. Nove, V. Rosen, and J.M. Wozney. 1994. A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. Biochem. Biophys. Res. Comm. 205: 1944-1951.
55. Zhang, H. and A. Bradley. 1996. Mice deficient for BMP-2 are non-viable and have defects in amnion/chorion and cardiac development. Development 122: 2977-2986.